France Covid-19 Vaccine Development Tools Market Size & Outlook
France covid-19 vaccine development tools market, 2020-2028 (US$M)
Related Markets
France covid-19 vaccine development tools market highlights
- The France covid-19 vaccine development tools market generated a revenue of USD 671.9 million in 2020 and is expected to reach USD 1,410.3 million by 2028.
- The France market is expected to grow at a CAGR of 9.7% from 2021 to 2028.
- In terms of segment, laboratory technologies was the largest revenue generating technologies in 2020.
- Online Technologies is the most lucrative technologies segment registering the fastest growth during the forecast period.
Covid-19 vaccine development tools market data book summary
| Market revenue in 2020 | USD 671.9 million |
| Market revenue in 2028 | USD 1,410.3 million |
| Growth rate | 9.7% (CAGR from 2020 to 2028) |
| Largest segment | Laboratory technologies |
| Fastest growing segment | Online Technologies |
| Historical data | 2020 - 2019 |
| Base year | 2020 |
| Forecast period | 2021 - 2028 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Laboratory Technologies, Online Technologies |
| Key market players worldwide | Thermo Fisher Scientific Inc, Pfizer Inc, Sartorius AG, Stemcell Holdings Inc Ordinary Shares, Illumina Inc, Agilent Technologies Inc, Bio-Rad Laboratories Inc, Danaher Corp, Merck KGaA, Qiagen NV, Shimadzu Corp, Eurofins Scientific SE, Charles River Laboratories International Inc, Takara Bio Inc, Olympus Corp, Avantor Inc, Aurora Innovation Inc Class A, Standard BioTools Inc, Celerion, Cole-Parmer, Hartford Schroders International Stk I, Revvity Inc, Fluidigm Corporation, Polyplus-transfection, Hamilton Lane Inc Class A |
Other key industry trends
- In terms of revenue, France accounted for 4.2% of the global covid-19 vaccine development tools market in 2020.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2028.
- In Europe, Germany covid-19 vaccine development tools market is projected to lead the regional market in terms of revenue in 2028.
- Spain is the fastest growing regional market in Europe and is projected to reach USD 264.1 million by 2028.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
COVID-19 Vaccine Development Tools Market Scope
COVID-19 Vaccine Development Tools Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
France covid-19 vaccine development tools market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to covid-19 vaccine development tools market will help companies and investors design strategic landscapes.
Laboratory technologies was the largest segment with a revenue share of 95.25% in 2020. Horizon Databook has segmented the France covid-19 vaccine development tools market based on laboratory technologies, online technologies covering the revenue growth of each sub-segment from 2020 to 2028.
France is a developing market with a steady growth rate. However, the region received considerable attention from the UK, Australia, and other private players for its innovation in COVID-19 vaccine development. Valneva, a French company, developed VLA2001, a COVID-19 vaccine candidate that is the only whole virus, inactivated, adjuvanted with CpG 1018 and Alum in Europe.
The company used its commercial Japanese Encephalitis (JE) vaccine platform to manufacture the vaccine. VLA2001 can build a strong immune system, capable of handling emerging variants of the virus. Although it is under phase 3 of clinical trials, the UK government has pre-ordered more than 100 million doses of the vaccine.
Moreover, Australia and a few European countries are in discussion with the company to import the vaccine. Furthermore, in October 2021-September 2022 budget of ACT accelerator Strategic Plan by WHO, the region has been allocated 0.74% of budget funds.
Reasons to subscribe to France covid-19 vaccine development tools market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of France covid-19 vaccine development tools market databook
-
Our clientele includes a mix of covid-19 vaccine development tools market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the France covid-19 vaccine development tools market , including forecasts for subscribers. This country databook contains high-level insights into France covid-19 vaccine development tools market from 2020 to 2028, including revenue numbers, major trends, and company profiles.
Partial client list
France covid-19 vaccine development tools market size, by technologies, 2020-2028 (US$M)
France COVID-19 Vaccine Development Tools Market Outlook Share, 2020 & 2028 (US$M)
Related industry reports
Related regional statistics
No records
No related regions found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
